Mount Sinai Tisch Cancer Center is a National Cancer Institute-designated comprehensive cancer center that uses a multidisciplinary approach to research and treatment aimed at advancing clinical breakthroughs in cancer care. Established in 2008 as The Tisch Cancer Institute, the center’s faculty includes more than 150 scientists and physicians who build on Mount Sinai Health System’s legacy of biomedical discovery and medical and scientific training. Mount Sinai Tisch Cancer Center’s centers of excellence pair novel research and clinical trials with coordinated care teams spanning cancer types including breast, gynecologic, genitourinary, head and neck, lung and thoracic, and skin cancers. Investigators collaborate across disciplines to advance treatments such as immunotherapy, translating research into patient care from diagnosis through survivorship. Through its Cancer Network, the center also extends prevention, screening, education and treatment services, including clinical trial access, to surrounding communities. Patients treated at the center have access to the full range of services at The Mount Sinai Hospital, the No. 1 academic medical center in the New York metropolitan area and the No. 10-ranked hospital nationally for cancer by U.S. News & World Report for 2026-27.
